Search

Author/Creator Shemesh, Colby S.

1. Integrated Two‐Analyte Population Pharmacokinetic Model of Polatuzumab Vedotin in Patients With Non‐Hodgkin Lymphoma. (23rd December 2019)

Authors:
Lu, Dan; Lu, Tong; Gibiansky, Leonid; Li, Xiaobin; Li, Chunze; Agarwal, Priya; Shemesh, Colby S.; Shi, Rong; Dere, Randall C.; Hirata, Jamie; Miles, Dale; Chanu, Pascal; Girish, Sandhya; Jin, Jin Yan
Journal:
CPT: pharmacometrics & systems pharmacology
Issue:
Volume 9:Number 1(2020)
Page Start:
48
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Pan‐cancer population pharmacokinetics and exposure‐safety and ‐efficacy analyses of atezolizumab in patients with high tumor mutational burden. Issue 6 (25th November 2020)

Authors:
Shemesh, Colby S.; Chan, Phyllis; Legrand, Fatema A.; Shames, David S.; Das Thakur, Meghna; Shi, Jane; Bailey, Lorna; Vadhavkar, Shweta; He, Xian; Zhang, Wei; Bruno, René
Journal:
Pharmacology research & perspectives
Issue:
Volume 8:Issue 6(2020)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Population pharmacokinetics, exposure-safety, and immunogenicity of atezolizumab in pediatric and young adult patients with cancer. Issue 1 (21st November 2019)

Authors:
Shemesh, Colby S.; Chanu, Pascal; Jamsen, Kris; Wada, Russ; Rossato, Gianluca; Donaldson, Francis; Garg, Amit; Winter, Helen; Ruppel, Jane; Wang, Xin; Bruno, Rene; Jin, Jin; Girish, Sandhya
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗